Evidence map›Paper›PMID 41703914›Full record

ArticleACS applied materials & interfaces2026

Regulation of Chemical Transformation in Designer Peptide Biomolecular Condensates.

Shirel Veretnik, Avigail Baruch Leshem, Ayala Lampel

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shirel VeretnikShmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.
Avigail Baruch LeshemShmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.
Ayala LampelShmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0003-2733-9197

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomolecular condensates, formed through liquid-liquid phase separation, serve as dynamic platforms for biochemical regulation. Inspired by these natural systems, we develop designer peptide-based condensates to modulate chemical transformations, focusing on the Cu(I)-catalyzed azide-alkyne cycloaddition click reaction between hydrophobic reactants as a model system. By incorporating a varying number of isoleucine residues into peptide sequences, we tune the hydrophobicity of the condensates. This variation allows us to tune condensate properties, including reactant recruitment, internal mobility, and catalytic performance. We show that peptide hydrophobicity dictates selective partitioning of the hydrophobic azide reactant into the dense phase, while increased hydrophobicity reduces internal diffusion. Higher molecular mobility within the condensates correlates with increased reaction rates and product formation, leading to enhanced spatially localized reactivity within the condensates. Together, our findings establish a mechanistic framework linking the peptide sequence, condensate dynamics, and compartmentalized catalysis. This work provides a foundation for using designer condensates as programmable microreactors for sustainable chemistry and biomedical applications.

Indexed as

Biomolecular CondensatesPeptidesAlkynesAzidesCatalysisClick ChemistryCopperCycloaddition ReactionHydrophobic and Hydrophilic InteractionsPhase SeparationAlkynesAzidesCopperPeptidesclick chemistrycompartmentalizationcondensatesCuAACliquid−liquid phase separationpeptidesreaction

Identifiers

PMID41703914
PMCPMC12964334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.